{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:33:15Z","timestamp":1785522795376,"version":"3.56.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanghai Xinxin Medical Technology Development Foundation","award":["KY-HXZ-20240511-001"],"award-info":[{"award-number":["KY-HXZ-20240511-001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-05124-4","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:26:15Z","timestamp":1781519175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of HA130\/KHA80 hemoperfusion combined with hemodialysis with survival outcomes in patients receiving maintenance hemodialysis: a time-dependent and propensity score-matched analysis"],"prefix":"10.1186","volume":"27","author":[{"given":"Yan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"5124_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"A Francis","year":"2024","unstructured":"Francis A, Harhay MN, Ong ACM, Tummalapalli SL, Ortiz A, Fogo AB, et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024;20:473\u201385. https:\/\/doi.org\/10.1038\/s41581-024-00820-6.","journal-title":"Nat Rev Nephrol"},{"key":"5124_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000514550","volume":"52","author":"JS Thurlow","year":"2021","unstructured":"Thurlow JS, Joshi M, Yan G, Norris KC, Agodoa LY, Yuan CM, et al. Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy. Am J Nephrol. 2021;52:98\u2013107. https:\/\/doi.org\/10.1159\/000514550.","journal-title":"Am J Nephrol"},{"key":"5124_CR3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41581-022-00542-7","volume":"18","author":"AK Bello","year":"2022","unstructured":"Bello AK, Okpechi IG, Osman MA, Cho Y, Htay H, Jha V, et al. Epidemiology of haemodialysis outcomes. Nat Rev Nephrol. 2022;18:378\u201395. https:\/\/doi.org\/10.1038\/s41581-022-00542-7.","journal-title":"Nat Rev Nephrol"},{"key":"5124_CR4","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3390\/toxins13040246","volume":"13","author":"S Magnani","year":"2021","unstructured":"Magnani S, Atti M. Uremic Toxins and Blood Purification: A Review of Current Evidence and Future Perspectives. Toxins (Basel). 2021;13:246. https:\/\/doi.org\/10.3390\/toxins13040246.","journal-title":"Toxins (Basel)"},{"key":"5124_CR5","doi-asserted-by":"publisher","first-page":"100299","DOI":"10.1016\/j.impact.2021.100299","volume":"21","author":"S Daneshamouz","year":"2021","unstructured":"Daneshamouz S, Eduok U, Abdelrasoul A, Shoker A. Protein-bound uremic toxins (PBUTs) in chronic kidney disease (CKD) patients: Production pathway, challenges and recent advances in renal PBUTs clearance. NanoImpact. 2021;21:100299. https:\/\/doi.org\/10.1016\/j.impact.2021.100299.","journal-title":"NanoImpact"},{"key":"5124_CR6","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/ndt\/gfr453","volume":"27","author":"I-W Wu","year":"2012","unstructured":"Wu I-W, Hsu K-H, Hsu H-J, Lee C-C, Sun C-Y, Tsai C-J, et al. Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients\u2013a prospective cohort study. Nephrol Dial Transpl. 2012;27:1169\u201375. https:\/\/doi.org\/10.1093\/ndt\/gfr453.","journal-title":"Nephrol Dial Transpl"},{"key":"5124_CR7","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1038\/s41598-021-83383-x","volume":"11","author":"P-H Wu","year":"2021","unstructured":"Wu P-H, Lin Y-T, Chiu Y-W, Baldanzi G, Huang J-C, Liang S-S, et al. The relationship of indoxyl sulfate and p-cresyl sulfate with target cardiovascular proteins in hemodialysis patients. Sci Rep. 2021;11:3786. https:\/\/doi.org\/10.1038\/s41598-021-83383-x.","journal-title":"Sci Rep"},{"key":"5124_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12882-024-03503-3","volume":"25","author":"W Yip","year":"2024","unstructured":"Yip W, Ng SHX, Kaur P, George PP, Guan JHC, Lee G, et al. Risk factors for short-term all-cause mortality in patients with end stage renal disease: a scoping review. BMC Nephrol. 2024;25:71. https:\/\/doi.org\/10.1186\/s12882-024-03503-3.","journal-title":"BMC Nephrol"},{"issue":"10","key":"5124_CR9","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1159\/000525952","volume":"51","author":"W Lu","year":"2022","unstructured":"Lu W, Jiang G, on behalf of Shanghai HP-HD Consensus Group. Hemoperfusion in Maintenance Hemodialysis Patients. Blood Purif. 2022;51(10):803\u201311. https:\/\/doi.org\/10.1159\/000525952.","journal-title":"Blood Purif"},{"key":"5124_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/aor.12961","volume":"42","author":"S Yamamoto","year":"2018","unstructured":"Yamamoto S, Sato M, Sato Y, Wakamatsu T, Takahashi Y, Iguchi A, et al. Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis. Artif Organs. 2018;42:88\u201393. https:\/\/doi.org\/10.1111\/aor.12961.","journal-title":"Artif Organs"},{"key":"5124_CR11","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/S0140-6736(25)01853-7","volume":"406","author":"PB Mark","year":"2025","unstructured":"Mark PB, Stafford LK, Grams ME, Aalruz H, ElHafeez SA, Abdelgalil AA, et al. Global, regional, and national burden of chronic kidney disease in adults, 1990\u20132023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. 2025;406:2461\u201382. https:\/\/doi.org\/10.1016\/S0140-6736(25)01853-7.","journal-title":"Lancet"},{"key":"5124_CR12","doi-asserted-by":"publisher","unstructured":"Boyle NG, Do DH. Hemodialysis patients: high risk for sudden death, but what is the cause? JACC Clin Electrophysiol. 2018;4:409\u201311. https:\/\/doi.org\/10.1016\/j.jacep.2017.09.005.","DOI":"10.1016\/j.jacep.2017.09.005"},{"key":"5124_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s43044-025-00606-6","volume":"77","author":"S Chander","year":"2025","unstructured":"Chander S, Aamir AB, Latif R, Parkash O, Sorath FNU, Tan S, et al. Type of arrhythmias and the risk of sudden cardiac death in dialysis patients: a systematic review and meta-analysis. Egypt Heart J. 2025;77:11. https:\/\/doi.org\/10.1186\/s43044-025-00606-6.","journal-title":"Egypt Heart J"},{"key":"5124_CR14","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1038\/s41467-026-71079-7","volume":"17","author":"W Lu","year":"2026","unstructured":"Lu W, Zhang X, Guo Z, Deng Y, Ni Z, Zhou R, et al. Hemoadsorption combined with hemodialysis versus hemodialysis alone on mortality in end-stage kidney disease: a randomized, open-label, multicenter trial. Nat Commun. 2026;17:4537. https:\/\/doi.org\/10.1038\/s41467-026-71079-7.","journal-title":"Nat Commun"},{"key":"5124_CR15","doi-asserted-by":"publisher","first-page":"672","DOI":"10.23876\/j.krcp.23.115","volume":"42","author":"Y-I Jo","year":"2023","unstructured":"Jo Y-I. Removal of uremic toxin by dialysis, what is the issue? Kidney Res Clin Pract. 2023;42:672\u20135. https:\/\/doi.org\/10.23876\/j.krcp.23.115.","journal-title":"Kidney Res Clin Pract"},{"key":"5124_CR16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.arcmed.2014.04.002","volume":"45","author":"M Rossi","year":"2014","unstructured":"Rossi M, Campbell KL, Johnson DW, Stanton T, Vesey DA, Coombes JS, et al. Protein-bound Uremic Toxins, Inflammation and Oxidative Stress: A Cross-sectional Study in Stage 3\u20134 Chronic Kidney Disease. Arch Med Res. 2014;45:309\u201317. https:\/\/doi.org\/10.1016\/j.arcmed.2014.04.002.","journal-title":"Arch Med Res"},{"key":"5124_CR17","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s40620-022-01271-7","volume":"35","author":"T Arcidiacono","year":"2022","unstructured":"Arcidiacono T, Macrina L, Premaschi S, Bologna A, Magni G, Foligno N, et al. Serum concentrations of free indoxyl and p-cresyl sulfate are associated with mineral metabolism variables and cardiovascular risk in hemodialysis patients. J Nephrol. 2022;35:1457\u201365. https:\/\/doi.org\/10.1007\/s40620-022-01271-7.","journal-title":"J Nephrol"},{"key":"5124_CR18","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/j.1523-1755.2004.00399.x","volume":"65","author":"L Dou","year":"2004","unstructured":"Dou L, Bertrand E, Cerini C, Faure V, Sampol J, Vanholder R, et al. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int. 2004;65:442\u201351. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00399.x.","journal-title":"Kidney Int"},{"key":"5124_CR19","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1111\/j.1538-7836.2007.02540.x","volume":"5","author":"L Dou","year":"2007","unstructured":"Dou L, Jourde-Chiche N, Faure V, Cerini C, Berland Y, Dignat-George F, et al. The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells. J Thromb Haemost. 2007;5:1302\u20138. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02540.x.","journal-title":"J Thromb Haemost"},{"key":"5124_CR20","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1681\/ASN.2012030281","volume":"24","author":"A Pletinck","year":"2013","unstructured":"Pletinck A, Glorieux G, Schepers E, Cohen G, Gondouin B, Van Landschoot M, et al. Protein-bound uremic toxins stimulate crosstalk between leukocytes and vessel wall. J Am Soc Nephrol. 2013;24:1981\u201394. https:\/\/doi.org\/10.1681\/ASN.2012030281.","journal-title":"J Am Soc Nephrol"},{"key":"5124_CR21","doi-asserted-by":"publisher","first-page":"1500336","DOI":"10.3389\/fendo.2025.1500336","volume":"16","author":"S Zhang","year":"2025","unstructured":"Zhang S, Tang S, Liu Y, Xue B, Xie Q, Zhao L, et al. Protein-bound uremic toxins as therapeutic targets for cardiovascular, kidney, and metabolic disorders. Front Endocrinol (Lausanne). 2025;16:1500336. https:\/\/doi.org\/10.3389\/fendo.2025.1500336.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5124_CR22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1900\/RDS.2010.7.275","volume":"7","author":"C-A Chiu","year":"2010","unstructured":"Chiu C-A, Lu L-F, Yu T-H, Hung W-C, Chung F-M, Tsai I-T, et al. Increased Levels of Total P-Cresylsulphate and Indoxyl Sulphate are Associated with Coronary Artery Disease in Patients with Diabetic Nephropathy. Rev Diabet Stud. 2010;7:275\u201384. https:\/\/doi.org\/10.1900\/RDS.2010.7.275.","journal-title":"Rev Diabet Stud"},{"issue":"2","key":"5124_CR23","doi-asserted-by":"publisher","first-page":"F380","DOI":"10.1152\/ajprenal.00175.2010","volume":"299","author":"F Palm","year":"2010","unstructured":"Palm F, Nangaku M, Fasching A, Tanaka T, Nordquist L, Hansell P, et al. Uremia induces abnormal oxygen consumption in tubules and aggravates chronic hypoxia of the kidney via oxidative stress. Am J Physiol Ren Physiol. 2010;299(2):F380\u20136. https:\/\/doi.org\/10.1152\/ajprenal.00175.2010.","journal-title":"Am J Physiol Ren Physiol"},{"key":"5124_CR24","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/ki.2014.419","volume":"87","author":"J Floege","year":"2015","unstructured":"Floege J, Gillespie IA, Kronenberg F, Anker SD, Gioni I, Richards S, et al. Development and validation of a predictive mortality risk score from a European hemodialysis cohort. Kidney Int. 2015;87:996\u20131008. https:\/\/doi.org\/10.1038\/ki.2014.419.","journal-title":"Kidney Int"},{"key":"5124_CR25","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.2215\/CJN.03980609","volume":"4","author":"FC Barreto","year":"2009","unstructured":"Barreto FC, Barreto DV, Liabeuf S, Meert N, Glorieux G, Temmar M, et al. Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients. Clin J Am Soc Nephrol. 2009;4:1551\u20138. https:\/\/doi.org\/10.2215\/CJN.03980609.","journal-title":"Clin J Am Soc Nephrol"},{"key":"5124_CR26","doi-asserted-by":"publisher","first-page":"C1201","DOI":"10.1152\/ajpcell.00471.2010","volume":"301","author":"H Shimizu","year":"2011","unstructured":"Shimizu H, Bolati D, Adijiang A, Muteliefu G, Enomoto A, Nishijima F, et al. NF-\u03baB plays an important role in indoxyl sulfate-induced cellular senescence, fibrotic gene expression, and inhibition of proliferation in proximal tubular cells. Am J Physiol Cell Physiol. 2011;301:C1201\u20131212. https:\/\/doi.org\/10.1152\/ajpcell.00471.2010.","journal-title":"Am J Physiol Cell Physiol"},{"key":"5124_CR27","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/ki.2012.448","volume":"83","author":"H Watanabe","year":"2013","unstructured":"Watanabe H, Miyamoto Y, Honda D, Tanaka H, Wu Q, Endo M, et al. p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Kidney Int. 2013;83:582\u201392. https:\/\/doi.org\/10.1038\/ki.2012.448.","journal-title":"Kidney Int"},{"key":"5124_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1053\/j.ajkd.2004.08.008","volume":"44","author":"F Locatelli","year":"2004","unstructured":"Locatelli F, Pisoni RL, Akizawa T, Cruz JM, DeOreo PB, Lameire NH, et al. Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K\/DOQI) guidelines and Dialysis Outcomes and Practice Patterns Study (DOPPS) findings. Am J Kidney Dis. 2004;44:27\u201333. https:\/\/doi.org\/10.1053\/j.ajkd.2004.08.008.","journal-title":"Am J Kidney Dis"},{"key":"5124_CR29","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/ki.2008.31","volume":"73","author":"BKI Meijers","year":"2008","unstructured":"Meijers BKI, Bammens B, De Moor B, Verbeke K, Vanrenterghem Y, Evenepoel P. Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int. 2008;73:1174\u201380. https:\/\/doi.org\/10.1038\/ki.2008.31.","journal-title":"Kidney Int"},{"key":"5124_CR30","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10157-011-0573-3","volume":"16","author":"R Furuya","year":"2012","unstructured":"Furuya R, Kumagai H, Miyata T, Fukasawa H, Isobe S, Kinoshita N, et al. High plasma pentosidine level is accompanied with cardiovascular events in hemodialysis patients. Clin Exp Nephrol. 2012;16:421\u20136. https:\/\/doi.org\/10.1007\/s10157-011-0573-3.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"5124_CR31","doi-asserted-by":"publisher","first-page":"2590874","DOI":"10.1080\/0886022X.2025.2590874","volume":"47","author":"M Wang","year":"2025","unstructured":"Wang M, Hua W, Chen L, Tang L, Xiang X. Enhanced cognitive outcomes with triple-mode dialysis in kidney failure: role of protein-bound toxin clearance. Ren Fail. 2025;47(1):2590874. https:\/\/doi.org\/10.1080\/0886022X.2025.2590874.","journal-title":"Ren Fail"},{"key":"5124_CR32","doi-asserted-by":"publisher","first-page":"2642241","DOI":"10.1080\/0886022X.2026.2642241","volume":"48","author":"L-X Zou","year":"2026","unstructured":"Zou L-X, Wang X, Qian C-H, Zheng X-Q, Sun L. Effect of hemoperfusion plus hemodialysis on uremic toxins and anemia in patients with maintenance hemodialysis. Ren Fail. 2026;48:2642241. https:\/\/doi.org\/10.1080\/0886022X.2026.2642241.","journal-title":"Ren Fail"},{"key":"5124_CR33","doi-asserted-by":"publisher","first-page":"61626","DOI":"10.1021\/acsami.5c18435","volume":"17","author":"S Wang","year":"2025","unstructured":"Wang S, Chen Y, Tong D, Li Y, Su B, Zhao W. Adsorption Removal of Protein-Bound Uremic Toxins: Material Strategies, Dissociation Mechanisms, and Clinical Challenges. ACS Appl Mater Interfaces. 2025;17:61626\u201346. https:\/\/doi.org\/10.1021\/acsami.5c18435.","journal-title":"ACS Appl Mater Interfaces"},{"key":"5124_CR34","doi-asserted-by":"publisher","first-page":"e44927","DOI":"10.1097\/MD.0000000000044927","volume":"104","author":"S Jinwei","year":"2025","unstructured":"Jinwei S, Weikang M, Ying H, Yueqiang W, Ying Z, Dongxi H, et al. Systemic inflammation response index (SIRI) predicts mortality and cardiovascular events in maintenance hemodialysis patients: A correlational study. Med (Baltim). 2025;104:e44927. https:\/\/doi.org\/10.1097\/MD.0000000000044927.","journal-title":"Med (Baltim)"},{"key":"5124_CR35","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000545262","volume":"11","author":"Q Yang","year":"2025","unstructured":"Yang Q, Liu G, Guo M, Yuan D, Huang J, Zhou Z, et al. The Clinical Efficacy Evaluation of the KHA-200 Hemoperfusion Device in the Treatment of End-Stage Renal Disease Patients Undergoing Blood Purification Therapy. Kidney Dis (Basel). 2025;11:270\u201382. https:\/\/doi.org\/10.1159\/000545262.","journal-title":"Kidney Dis (Basel)"},{"key":"5124_CR36","doi-asserted-by":"publisher","first-page":"102529","DOI":"10.1016\/j.chempr.2025.102529","volume":"11","author":"X Ding","year":"2025","unstructured":"Ding X, Zhou X, Du B. Recent advances in membrane and sorbent design for blood purification in sepsis and septic shock. Chem. 2025;11:102529. https:\/\/doi.org\/10.1016\/j.chempr.2025.102529.","journal-title":"Chem"},{"key":"5124_CR37","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000542469","volume":"54","author":"Y Li","year":"2025","unstructured":"Li Y, Han M, Yang M, Su B. Hemoperfusion with the HA330\/HA380 Cartridge in Intensive Care Settings: A State-Of-The-Art Review. Blood Purif. 2025;54:122\u201337. https:\/\/doi.org\/10.1159\/000542469.","journal-title":"Blood Purif"},{"key":"5124_CR38","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1177\/15353702221097320","volume":"247","author":"T Duangchan","year":"2022","unstructured":"Duangchan T, Rattanasompattikul M, Chitchongyingcharoen N, Mas-Oodi S, Promkan M, Rongkiettechakorn N, et al. Indoxyl sulfate impairs in vitro erythropoiesis by triggering apoptosis and senescence. Exp Biol Med (Maywood). 2022;247:1350\u201363. https:\/\/doi.org\/10.1177\/15353702221097320.","journal-title":"Exp Biol Med (Maywood)"},{"key":"5124_CR39","doi-asserted-by":"publisher","first-page":"1198560","DOI":"10.3389\/fneph.2023.1198560","volume":"3","author":"G Echefu","year":"2023","unstructured":"Echefu G, Stowe I, Burka S, Basu-Ray I, Kumbala D. Pathophysiological concepts and screening of cardiovascular disease in dialysis patients. Front Nephrol. 2023;3:1198560. https:\/\/doi.org\/10.3389\/fneph.2023.1198560.","journal-title":"Front Nephrol"},{"key":"5124_CR40","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1046\/j.1523-1755.64.s87.6.x","volume":"64","author":"AA Pereira","year":"2003","unstructured":"Pereira AA, Sarnak MJ. Anemia as a risk factor for cardiovascular disease: Management of comorbidities in kidney disease in the 21st century: Anemia and bone disease. Kidney Int. 2003;64:S32\u20139. https:\/\/doi.org\/10.1046\/j.1523-1755.64.s87.6.x.","journal-title":"Kidney Int"},{"key":"5124_CR41","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/sdi.13110","volume":"36","author":"LH Sun","year":"2023","unstructured":"Sun LH. Effect of different hemodialysis modalities on hepcidin clearance in patients undergoing maintenance hemodialysis. Semin Dial. 2023;36:240\u20136. https:\/\/doi.org\/10.1111\/sdi.13110.","journal-title":"Semin Dial"},{"key":"5124_CR42","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000514187","volume":"51","author":"W Cheng","year":"2021","unstructured":"Cheng W, Luo Y, Wang H, Qin X, Liu X, Fu Y, et al. Survival Outcomes of Hemoperfusion and Hemodialysis versus Hemodialysis in Patients with End-Stage Renal Disease: A Systematic Review and Meta-Analysis. Blood Purif. 2021;51:213\u201325. https:\/\/doi.org\/10.1159\/000514187.","journal-title":"Blood Purif"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05124-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05124-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05124-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:19:14Z","timestamp":1785518354000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05124-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5124"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05124-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8739970\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This clinical study was approved by the Shanghai Changhai Hospital Ethics Committee (Ethics Approval No. CHEC2022-207, October 28, 2022). Ethics committee approval was obtained prior to data extraction and analysis; given the study\u2019s retrospective, non-interventional nature, the requirement for written informed consent was waived. All procedures and data handling were compliant with the ethical principles of the Declaration of Helsinki and institutional data protection policies. Patient information was anonymized prior to extraction, and only routinely recorded clinical data were analyzed.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"448"}}